Afluria - INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection 5 mL
NDC 33332-0125-10 is also written 33332012510, or 33332-125-10 (3333212510) in 10-digit form. Core reference details for licensed healthcare facility review and verification.
| NDC 11 | 33332-0125-10 |
|---|---|
| Product NDC | 33332-0125 |
| Generic Drug Name | INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED) |
| Brand Name | Afluria |
| Manufacturer | Seqirus PTY LTD. |
| Strength | 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL |
| Dosage Form | Injection |
| Drug Type | Intramuscular |
| Package Quantity | 1 Vial, Multi-Dose |
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (33332-125-10) / 5 mL in 1 VIAL, MULTI-DOSE (33332-125-11) |
| Active Ingredients | Influenza A Virus A/Croatia/10136Rv/2023 X-425A (H3N2) Antigen (Propiolactone Inactivated); Influenza A Virus A/Victoria/4897/2022 Ivr-238 (H1N1) Antigen (Propiolactone Inactivated); Influenza B Virus B/Austria/1359417/2021 Bvr-26 Antigen (Propiolactone Inactivated) |
| Marketing Category | BLA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
Core NDC snapshot
INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection is tracked under NDC 33332-0125-10 and rolls up into product family 33332-0125. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 1 Vial, Multi-Dose.
- Manufacturer: Seqirus PTY LTD..
- Dosage form: Injection.
- Family size: 1 indexed presentation.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Afluria - INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection 5 mL, NDC 33332-0125-10, is a Seqirus PTY LTD. 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL injection presentation packaged as 1 Vial, Multi-Dose.
NDC search formats
- Canonical NDC 11: 33332-0125-10
- Digits-only NDC 11: 33332012510
- Possible 10-digit display format: 33332-125-10 (3333212510)
Helpful product links
- Search by brand name: Afluria
- NDC 11: 33332-0125-10
- Product family NDC: 33332-0125
- VA classification code: IM100
- VA classification code description: VACCINES
- CMOP ID: I0554
- VUID: 4032609
